What question did this study set out to answer?

To assess longitudinal trends in the prescription of GLP-1RA and SGLT2i medications among different racial and ethnic groups from 2016 to 2023.

June 7, 2026Diabetes

2909-LB: Longitudinal Analysis of Variation by Race and Ethnicity in Prescription of GLP-1RA and SGLT2i Medications in Type 2 Diabetes

View Full Paper

Ask AI

Bookmark

Authors

HTHUGO A. TORRESLubbock Christian University TMTANNAZ MOINLubbock Christian University NJNICHOLAS JACKSONLubbock Christian University

Discussion

Member takes

Implication

Longitudinal analysis reveals disparities in GLP-1RA and SGLT2i prescriptions among racial groups in type 2 diabetes, indicating urgent need for equity interventions.

Key Points

To assess longitudinal trends in the prescription of GLP-1RA and SGLT2i medications among different racial and ethnic groups from 2016 to 2023.
Analyzed EHR data from adults with type 2 diabetes with indications for GLP-1RA or SGLT2i.
Employed cluster-robust linear probability modeling for prescription rates as a composite and separately.
Primary predictor was race/ethnicity with a race-by-calendar-year interaction term.
In 2016, Black patients had an 8.1% lower prescription rate compared to non-Hispanic White patients (p<0.001).
Asian patients showed a slower increase in GLP-1RA prescriptions during 2021-2023 (p<0.01).
Hispanic and Black patients' prescription rates did not change significantly relative to non-Hispanic White patients over time.

Cite This Study

TORRES et al. (2026) studied this question.

synapsesocial.com/papers/6a250a9a7def13d035e1aaee https://doi.org/10.2337/db26-2909-lb

View Full Paper

Ask AI

Bookmark

Implication

Longitudinal analysis reveals disparities in GLP-1RA and SGLT2i prescriptions among racial groups in type 2 diabetes, indicating urgent need for equity interventions.

2909-LB: Longitudinal Analysis of Variation by Race and Ethnicity in Prescription of GLP-1RA and SGLT2i Medications in Type 2 Diabetes

Discussion

Member takes

Implication

Key Points

Cite This Study

2909-LB: Longitudinal Analysis of Variation by Race and Ethnicity in Prescription of GLP-1RA and SGLT2i Medications in Type 2 Diabetes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider